Bruderman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-98,772
Closed -$5.84M 107
2021
Q3
$5.84M Sell
98,772
-46,616
-32% -$3.07M 1.47% 21
2021
Q2
$9.71M Buy
145,388
+1,505
+1% +$98.1K 3.01% 11
2021
Q1
$9.08M Buy
143,883
+3,186
+2% +$198K 2.52% 10
2020
Q4
$8.73M Buy
140,697
+5,333
+4% +$328K 2.53% 9
2020
Q3
$8.16M Buy
135,364
+58,108
+75% +$3.5M 2.68% 7
2020
Q2
$4.59M Buy
77,256
+1,259
+2% +$75.3K 1.52% 25
2020
Q1
$4.17M Sell
75,997
-1,708
-2% -$104K 1.65% 20
2019
Q4
$4.92M Sell
77,705
-6,120
-7% -$350K 1.54% 24
2019
Q3
$4.86M Buy
+83,825
New +$3.94M 1.23% 29
2019
Q2
Sell
-4,009
Closed -$191K 166
2019
Q1
$191K Sell
4,009
-129
-3% -$6.43K 0.04% 133
2018
Q4
$215K Buy
+4,138
New +$222K 0.06% 121
2017
Q1
Sell
-3,522
Closed -$206K 140
2016
Q4
$206K Sell
3,522
-1,100
-24% -$60.1K 0.06% 107
2016
Q3
$249K Buy
4,622
+364
+9% +$23.4K 0.07% 107
2016
Q2
$313K Buy
4,258
+15
+0.4% +$1.06K 0.1% 101
2016
Q1
$271K Buy
4,243
+17
+0.4% +$1.07K 0.09% 102
2015
Q4
$291K Sell
4,226
-1,500
-26% -$99.1K 0.11% 99
2015
Q3
$339K Buy
5,726
+248
+5% +$15.7K 0.13% 84
2015
Q2
$365K Buy
5,478
+209
+4% +$13.8K 0.14% 84
2015
Q1
$340K Buy
+5,269
New +$330K 0.13% 85

Other funds holding BMY

Bruderman Asset Management's BMY Position: Q4 2021 in Review

Bruderman Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 98,772 shares — an estimated $5.84M sold.

Bruderman Asset Management first reported a position in BMY in Q1 2015 and held it in 19 quarters. The position peaked at $9.71M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Bruderman Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Bruderman Asset Management sold 98,772 Bristol-Myers Squibb shares in Q4 2021, an estimated $5.84M.
  • Bruderman Asset Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 19 quarters.
  • Bruderman Asset Management's Bristol-Myers Squibb position peaked at $9.71M in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Bruderman Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.